Rankings
▼
Calendar
FBLG Q3 2025 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
FBLG
FibroBiologics, Inc. Common Stock
$17M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$231,000
Operating Income
-$5M
Net Income
-$6M
EPS (Diluted)
$-0.13
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$704,000
Balance Sheet
Total Assets
$9M
Total Liabilities
$9M
Stockholders' Equity
$125,000
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$231,000
$0
—
Operating Income
-$5M
-$3M
-50.3%
Net Income
-$6M
-$500,000
-1055.6%
← FY 2025
All Quarters
Q4 2025 →